Tiziana Life Sciences Ltd. Common Shares TLSA
$1.07
-4.46%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $7.00
- Implied Upside
- +554.2%
- Price Target Range
- $7.00 – $7.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-22 | BTIGThomas Shrader |
Reiterates | Buy | $7 |
| 2026-09-03 | BTIGThomas Shrader |
Initiates coverage on | Buy | $7 |
| 2022-06-13 | ThinkEquityAshok Kumar |
Initiates coverage on | Buy | $4 |
| 2021-04-12 | Zacks Investment ResearchJohn Vandermosten |
Initiates coverage on | Not rated | $8 |
| 2020-09-21 | HC Wainwright & Co. |
Maintains | Buy | $25 → $11 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $1.07
- Market Cap
- $136.17 million
- 52-Week Range
- $0.76 – $2.35
- Average Volume
- 623K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.